Inventor · disambiguated record
Israel Charo
Also filed as: CHARO ISRAEL · CHARO ISRAEL F
37 granted patents·4 pending applications·352 citations·filing 1990–2023
98Inventor score
Top patents by PatentIndex Score
41 records- 0197US11045469B2Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodiesCHEMOCENTRYX INC·Filed 2020·Granted Jun 29, 2021·5 cites·18 claims
- 0295US10583131B2Methods of treating pancreatic cancerCHEMOCENTRYX INC·Filed 2019·Granted Mar 10, 2020·8 cites·21 claims
- 0394US10398685B2Methods of treating pancreatic cancerCHEMOCENTRYX INC·Filed 2019·Granted Sep 3, 2019·6 cites·20 claims
- 0493US10251888B2Method of treating pancreatic cancerCHEMOCENTRYX INC·Filed 2017·Granted Apr 9, 2019·9 cites·8 claims
- 0591US5707815AMammalian monocyte chemoattractant protein receptors and assays using themUNIV CALIFORNIA·Filed 1995·Granted Jan 13, 1998·71 cites·17 claims
- 0690US11304952B2Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitorCHEMOCENTRYX INC·Filed 2018·Granted Apr 19, 2022·11 cites·16 claims
- 0789US11890276B2Methods of treating pancreatic cancerCHEMOCENTRYX INC·Filed 2021·Granted Feb 6, 2024·1 cites·23 claims
- 0887US10195188B2Method of treating pancreatic cancerCHEMOCENTRYX INC·Filed 2017·Granted Feb 5, 2019·2 cites·18 claims
- 0985US6132987ARecombinant mammalian monocyte chemotactic protein-1 (MCP-1) receptors (MCP-1R, CCR-2)UNIV CALIFORNIA·Filed 1995·Granted Oct 17, 2000·43 cites·28 claims
- 1084US11020394B2Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C—C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodiesCHEMOCENTRYX INC·Filed 2019·Granted Jun 1, 2021·1 cites·8 claims
- 1183US11116756B2Methods of treating pancreatic cancerCHEMOCENTRYX INC·Filed 2020·Granted Sep 14, 2021·1 cites·15 claims
- 1283US10568870B2Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitorsCHEMOCENTRYX INC·Filed 2017·Granted Feb 25, 2020·2 cites·10 claims
- 1381US10682344B2Method of treating liver fibrosisCHEMOCENTRYX INC·Filed 2017·Granted Jun 16, 2020·2 cites·20 claims
- 1481US5318899APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1990·Granted Jun 7, 1994·47 cites·8 claims
- 1575US5968902APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Oct 19, 1999·13 cites·24 claims
- 1675US2024100041A1Compositions and methods for treating inflammatory bowel disease using ccr9 inhibitor and anti-il-23 blocking antibodiesCHEMOCENTRYX INC·Filed 2023·Application pending·0 cites
- 1774US5935926APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Aug 10, 1999·11 cites·36 claims
- 1874US2022313668A1Method of treating liver fibrosisCHEMOCENTRYX INC·Filed 2022·Application pending·0 cites
- 1972US5686570APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Nov 11, 1997·17 cites·11 claims
- 2072US5686571APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Nov 11, 1997·17 cites·11 claims
- 2172US2021322410A1Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of c-c chemokine receptor type 9 (ccr9) and anti-alpha4beta7 integrin blocking antibodiesCHEMOCENTRYX INC·Filed 2021·Application pending·0 cites
- 2270US11883391B2Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodiesCHEMOCENTRYX INC·Filed 2021·Granted Jan 30, 2024·0 cites·8 claims
- 2368US11357760B2Method of treating liver fibrosisCHEMOCENTRYX INC·Filed 2020·Granted Jun 14, 2022·0 cites·20 claims
- 2466US2023023075A1Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitorCHEMOCENTRYX INC·Filed 2022·Application pending·0 cites
- 2564US7803560B2Methods of screening for antagonists of mammalian monocyte chemoattractant protein receptorsUNIV CALIFORNIA·Filed 2007·Granted Sep 28, 2010·0 cites·9 claims
- 2661US11744822B2Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitorsCHEMOCENTRYX INC·Filed 2020·Granted Sep 5, 2023·0 cites·10 claims
- 2761US5736339AMethod utilizing purified GP IIb-IIIa to detect the presence of platelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Apr 7, 1998·8 cites·1 claims
- 2861US5686568APlatelet aggregration inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Nov 11, 1997·5 cites·11 claims
- 2960US5344783APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1993·Granted Sep 6, 1994·23 cites·3 claims
- 3058US5958732APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Sep 28, 1999·7 cites·12 claims
- 3158US5843897APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Dec 1, 1998·4 cites·24 claims
- 3258US5807825APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Sep 15, 1998·4 cites·24 claims
- 3357US5756451APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted May 26, 1998·4 cites·13 claims
- 3454US5686566APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Nov 11, 1997·6 cites·11 claims
- 3554US5686569APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Nov 11, 1997·6 cites·11 claims
- 3654US5686567APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Nov 11, 1997·6 cites·88 claims
- 3742US5770564APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Jun 23, 1998·2 cites·36 claims
- 3841US5786333APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Jul 28, 1998·2 cites·288 claims
- 3939US5496724AGenes encoding platelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1993·Granted Mar 5, 1996·4 cites·6 claims
- 4038US5759999APlatelet aggregation inhibitorsCOR THERAPEUTICS INC·Filed 1995·Granted Jun 2, 1998·1 cites·36 claims
- 4135US5705606APeptides derived from GPIIIaCOR THERAPEUTICS INC·Filed 1993·Granted Jan 6, 1998·3 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Israel Charo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →